An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19
Open Access
- 2 March 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (9), 880-881
- https://doi.org/10.1001/jama.2020.24415
Abstract
This Medical Letter review summarizes the evidence underlying the US Food and Drug Administration’s emergency use authorization of bamlanivimab, an investigatioKeywords
This publication has 1 reference indexed in Scilit:
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19The New England Journal of Medicine, 2021